<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Carotid duplex ultrasonography is the noninvasive procedure of choice for evaluating ECAD </plain></SENT>
<SENT sid="1" pm="."><plain>However, carotid angiography should be performed before doing carotid endarterectomy </plain></SENT>
<SENT sid="2" pm="."><plain>Multivariate logistic regression analysis showed that significant prognostic variables for ECAD in an elderly population are (1) cigarette smoking, (2) serum total cholesterol, (3) serum <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> (inverse association), (4) <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, and (5) prior CAD </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with 80-100% ECAD develop a higher incidence of ABI and <z:hpo ids='HP_0002326'>TIA</z:hpo> than patients with 40-80% ECAD </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with 40-80% ECAD develop a higher incidence of ABI and <z:hpo ids='HP_0002326'>TIA</z:hpo> than patients with 0-40% ECAD </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with ECAD have a higher prevalence of prior CAD and develop a higher incidence of new coronary events than patients without ECAD </plain></SENT>
<SENT sid="6" pm="."><plain>In patients with ECAD, significant prognostic variables for new coronary events are (1) silent <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, (2) prior CAD, (3) serum <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> (inverse association), and (4) cigarette smoking </plain></SENT>
<SENT sid="7" pm="."><plain>Risk factors for ECAD and CAD should be treated in patients with ECAD </plain></SENT>
<SENT sid="8" pm="."><plain>Cigarette smoking must be stopped </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000822'>Hypertension</z:hpo>, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, and <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> should be treated </plain></SENT>
<SENT sid="10" pm="."><plain>Aspirin, 325 mg/d, should be administered to patients with ECAD </plain></SENT>
<SENT sid="11" pm="."><plain><z:chebi fb="0" ids="9589">Ticlopidine hydrochloride</z:chebi>, 250 mg two times per day should be considered in patients with ECAD who are unable to tolerate aspirin or who develop cerebrovascular events on aspirin </plain></SENT>
<SENT sid="12" pm="."><plain>Carotid endarterectomy should be considered in symptomatic patients with 70-99% ECAD </plain></SENT>
</text></document>